Abstract
An intrinsic property of Staphylococcus aureus is that it is naturally susceptible to virtually every antibiotic ever developed. Various mechanisms are responsible for multidrug resistance, but efflux pumps play a crucial role in the emergence of multidrug-resistant bacteria by expelling the antimicrobials from inside the cell. These membrane proteins are also involved in a variety of physiological roles. Therefore, there is a need to identify inhibitors and develop strategies to overcome multidrug resistance. One possible option is the use of efflux pump inhibitors (EPIs) in combination with already available antimicrobial agents/antibiotics. Different approaches have been developed for the evaluation of EPIs, ranging from high-throughput screening to bioassay-guided purification. The greatest hurdle to their clinical use is toxicity, as is the case for the existing EPIs, verapamil and reserpine. To date, no single EPI has been approved for use in clinical settings because of uncertainty around their potency and their intolerable adverse effects, particularly inhibition of cytochrome P450. Currently, the use of test active EPIs is limited to epidemiological studies. However, the search for more specific and effective EPIs will continue because of their significant benefits. The development of new chemotherapeutic agents requires contemplation of efflux pump substrate selectivity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bame J, Graf T, Junio H, Bussey R, Jarmusch S, El-Elimat T, Falkinham J, Oberlies N, Cech R, Cech N (2013) Sarothrin from Alkanna orientalis is an antimicrobial agent and efflux pump inhibitor. Planta Med 79:327–329. doi:10.1055/s-0032-1328259
Bay DC, Rommens KL, Turner RJ (2008) Small multidrug resistance proteins: a multidrug transporter family that continues to grow. Biochim Biophys Acta 1778:1814–1838. doi:10.1016/j.bbamem.2007.08.015
Bharate J, Singh S, Wani A, Sharma S, Joshi P, Khan I, Kumar A, Vishwakarma R, Bharate S (2015) Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump. Org Biomol Chem 13:5424–5431. doi:10.1039/c5ob00246j
Brooun A, Liu S, Lewis K (2000) A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 44:640–646. doi:10.1128/AAC.44.3.640-646.2000
Cabral V, Luo X, Junqueira E, Costa S, Mulhovo S, Duarte A, Couto I, Viveiros M, Ferreira M (2015) Enhancing activity of antibiotics against Staphylococcus aureus : Zanthoxylum capense constituents and derivatives. Phytomedicine 22:469–476. doi:10.1016/j.phymed.2015.02.003
Camilli A, Bassler BL (2006) Bacterial small-molecule signaling pathways. Science 311:1113–1116. doi:10.1126/science.1121357
Chakrabarty S, Roy M, Hazra B, Bhattacharya R (2002) Induction of apoptosis in human cancer cell lines by diospyrin, a plant-derived bisnaphthoquinonoid, and its synthetic derivatives. Cancer Lett 188:85–93. doi:10.1016/S0304-3835(02)00494-9
Chan B, Han X, Lui S, Wong C, Wang T, Cheung D, Cheng S, Ip M, Han S, Yang X, Jolivalt C, Lau C, Leung P, Fung K (2015) Combating against methicillin-resistant Staphylococcus aureus—two fatty acids from purslane (Portulaca oleracea L.) exhibit synergistic effects with erythromycin. J Pharm Pharmacol 67:107–116. doi:10.1111/jphp.12315
Chitemerere T, Mukanganyama S (2014) Evaluation of cell membrane integrity as a potential antimicrobial target for plant products. BMC Complement Altern Med 14:278. doi:10.1186/1472-6882-14-278
Costa SS, Viveiros M, Amaral L, Couto I (2013) Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol J 7(Suppl 1-M5):59–71. doi:10.2174/1874285801307010059
Davidson AL, Chen J (2004) ATP-binding cassette transporters in bacteria. Annu Rev Biochem 73:41–268. doi:10.1146/annurev.biochem.73.011303.073626
Dawson RJP, Locher KP (2006) Structure of a bacterial multidrug ABC transporter. Nature 443:180–185. doi:10.1038/nature05155
Dwivedi G, Maurya A, Yadav D, Khan F, Darokar M, Srivastava S (2014) Drug resistance reversal potential of ursolic acid derivatives against nalidixic acid- and multidrug-resistant Escherichia coli. Chem Biol Drug Des 86(3):272–283. doi:10.1111/cbdd.12491
Fernandez L, Hancock R (2012) Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev 25:661–681. doi:10.1128/CMR.00043-12
Ferreira S, Silva F, Queiroz J, Oleastro M, Domingues F (2014) Resveratrol against Arcobacter butzleri and Arcobacter cryaerophilus: activity and effect on cellular functions. Int J Food Microbiol 180:62–68. doi:10.1016/j.ijfoodmicro.2014.04.004
Garzoni C, Kelley WL (2009) Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol 17:59–65. doi:10.1016/j.tim.2008.11.005
Gibbons S, Udo EE (2000) The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Phytother Res 14:139–140. doi:10.1002/(SICI)1099-1573(200003)14:2<139::AID-PTR608>3.0.CO;2-8
Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski BH (2005) Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 49:3858–3867. doi:10.1128/AAC.49.9.3858-3867.2005
Groeblacher B, Maier V, Kunert O, Bucar F (2012) Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta. J Nat Prod 75:1393–1399. doi:10.1021/np300375t
Handzlik J, Matys A, Kiec-Kononowicz K (2013) Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of gram-positive bacteria S. aureus. Antibiotics 2:28–45. doi:10.3390/antibiotics2010028
Kalia NP, Mahajan P, Mehra R, Nargotra A, Sharma JP, Koul S, Khan IA (2012) Capsaicin, a novel inhibitor of NorA efflux pump reduces the intracellular invasion of Staphylococcus aureus. J Antimicrob Chemother 67:2401–2408. doi:10.1093/jac/dks232
Khan IA, Mirza ZM, Kumar A, Verma V, Qazi GN (2006) Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 50:810–812. doi:10.1128/AAC.50.2.810-812.2006
Kourtesi C, Ball A, Huang Y, Jachak S, Vera D, Khondkar P, Gibbons S, Hamblin M, Tegos G (2013) Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J 7:34–52. doi:10.2174/1874285801307010034
Kriengkauykiat J, Porter E, Lomovskaya O, Wong-Beringer A (2005) Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:565–570. doi:10.1128/AAC.49.2.565-570.2005
Kristiansen J, Amaral L (1997) The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 40:319–327. doi:10.1093/jac/40.3.319
Krulwich TA, Lewinson O, Padan E, Bibi E (2005) Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study. Nat Rev Microbiol 3:566–572. doi:10.1038/nrmicro1181
Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57:1486–1513. doi:10.1016/j.addr.2005.04.004
Kumar S, Mukherjee MM, Varela M (2013) Modulation of bacterial multidrug resistance efflux pumps of the major facilitator superfamily. Int J Bacteriol 2013:Article ID 204141, 15 pages. doi:10.1155/2013/204141
Kuroda T, Tsuchiya T (2009) Multidrug efflux transporters in the MATE family. Biochim Biophys Acta 1794(5):763–768. doi:10.1016/j.bbapap.2008.11.012
Lechner D, Gibbon S, Bucar F (2008) Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J Antimicrob Chemother 62:345–348. doi:10.1093/jac/dkn178
Li XZ, Nikaido H (2004) Efflux-mediated drug resistance in bacteria. Drugs 64:159–204. doi:10.2165/00003495-200464020-00004
Li XZ, Poole K, Nikaido H (2003) Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother 47:27–33. doi:10.1128/AAC.47.1.27-33.2003
Limtrakul P, Khantamat O, Pintha K (2005) Inhibition of P-glycoprotein function and expression by kaempferol and quercetin. J Chemother 17:86–95. doi:10.1179/joc.2005.17.1.86
Lomovskaya O, Bostian KA (2006) Practical applications and feasibility of efflux pump inhibitors in the clinic—a vision for applied use. Biochem Pharmacol 71:910–918. doi:10.1016/j.bcp.2005.12.008
Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O’Toole GA (2003) A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306–310. doi:10.1038/nature02122
Maisuria VB, Hosseinidoust Z, Tufenkji N (2015) Polyphenolic extract from maple syrup potentiates antibiotic susceptibility and reduces biofilm formation of pathogenic bacteria. Appl Environ Microbiol 81:3782–3792. doi:10.1128/AEM.00239-15
Mullin S, Mani N, Grossman TH (2004) Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853). Antimicrob Agents Chemother 48:4171–4176. doi:10.1128/AAC.48.11.4171-4176.2004
Nikaido H, Takatsuka Y (2009) Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta 1794:769–781. doi:10.1016/j.bbapap.2008.10.004
Nishino K, Nikaido E, Yamaguchi A (2009) Regulation and physiological function of multidrug efflux pumps in Escherichia coli and salmonella. Biochem Biophys Acta 1794(5):834–843. doi:10.1016/j.bbapap.2009.02.002
Ojeda-Sana A, Repetto V, Moreno S (2013) Carnosic acid is an efflux pumps modulator by dissipation of the membrane potential in Enterococcus faecalis and Staphylococcus aureus. World J Microbiol Biotechnol 29:137–144. doi:10.1007/s11274-012-1166-3
Omote H, Hiasa M, Matsumoto T, Otsuka M, Moriyama Y (2006) The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations. Trends Pharmacol Sci 27:587–593. doi:10.1016/j.tips.2006.09.001
Piddock LJ (2006a) The AcrAB-TolC efflux system of serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 8:847–856. doi:10.1111/j.1462-5822.2005.00671.x
Piddock LJV (2006b) Multidrug-resistance efflux pumps—not just for resistance. Nat Rev Microbiol 4:629–636. doi:10.1038/nrmicro1464
Ramalhete C, Molnar J, Mulhovo S, Rosario V, Ferreira M (2009) New potent P-glycoprotein modulators with the cucurbitane scaffold and their synergistic interaction with doxorubicin on resistant cancer cells. Bioorg Med Chem 17:6942–6951. doi:10.1016/j.bmc.2009.08.020
Ramalhete C, Spengler G, Martins A, Martins M, Viveiros M, Mulhovo S, Ferreira M, Amaral L (2011) Inhibition of efflux pumps in meticillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina. Int J Antimicrob Agents 37:70–74. doi:10.1016/j.ijantimicag.2010.09.011
Renau TE, Leger R, Flamme EM, Sangalang J, She MW, Yen R, Gannon CL, Griffith D, Chamberland S, Lomovskaya O, Hecker SJ, Lee VJ, Ohta T, Nakayama K (1999) Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem 42:4928–4931. doi:10.1021/jm9904598
Roy SK, Pahwa S, Nandanwar H, Jachak SM (2012) Phenylpropanoids of Alpinia galanga as efflux pump inhibitors in Mycobacterium smegmatis mc2 155. Fitoterapia 83:1248–1255. doi:10.1016/j.fitote.2012.06.008
Roy S, Kumari N, Gupta S, Pahwa S, Nandanwar H, Jachak S (2013a) 7-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc(2) 155. Eur J Med Chem 66:499–507. doi:10.1016/j.ejmech.2013.06.024
Roy S, Kumari N, Pahwa S, Agrahari U, Bhutani K, Jachak S, Newman D (2013b) NorA efflux pump inhibitory activity of coumarins from Mesua ferrea. Fitoterapia 90:140–150. doi:10.1016/j.fitote.2013.07.015
Sewanu S, Bongekile M, Folusho O, Adejumobi L, Rowland O (2015) Antimicrobial and efflux pumps inhibitory activities of Eucalyptus grandis essential oil against respiratory tract infectious bacteria. J Med Plant Res 9:343–348. doi:10.5897/JMPR2015
Sharma S, Kalia NP, Suden P, Chauhan PS, Kumar M, Ram AB, Khajuria A, Bani S, Khan IA (2014) Protective efficacy of piperine against Mycobacterium tuberculosis. Tuberculosis 94:389–396. doi:10.1016/j.tube.2014.04.007
Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46:668–674. doi:10.1086/527392
Stavri M, Piddock L, Gibbons S (2007) Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 59:1247–1260. doi:10.1093/jac/dkl460
Tegos GP, Haynes M, Jacob Strouse J, Khan MMT, Bologa CG, Oprea TI, Sklar LA (2011) Microbial efflux pump inhibition: tactics and strategies. Curr Pharm Des 17:1291–1302. doi:10.2174/138161211795703726
Ughachukwu PO, Unekwe PC (2012) Efflux pump mediated resistance in chemotherapy. Ann Med Health Sci Res 2:191–198. doi:10.4103/2141-9248.105671
Zloh M, Kaatz GW, Gibbons S (2004) Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates. Bioorg Med Chem Lett 14:881–885. doi:10.1016/j.bmcl.2003.12.015
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kalia, N.P. (2017). Efflux-Mediated Drug Resistance in Staphylococcus aureus . In: Arora, G., Sajid, A., Kalia, V. (eds) Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-48683-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-48683-3_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48682-6
Online ISBN: 978-3-319-48683-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)